A citation-based method for searching scientific literature

Lu Huo, Jiao Jiao Li, Ling Chen, Zuguo Yu, Gyorgy Hutvagner, Jinyan Li. Brief Bioinform 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Structure-based drug design strategies in medicinal chemistry.
Adriano D Andricopulo, Lívia B Salum, Donald J Abraham. Curr Top Med Chem 2009
81
100

Structural biology in the time of COVID-19: perspectives on methods and milestones.
Miranda L Lynch, Edward H Snell, Sarah E J Bowman. IUCrJ 2021
2
100


Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
Andreas Greinacher, Thomas Thiele, Theodore E Warkentin, Karin Weisser, Paul A Kyrle, Sabine Eichinger. N Engl J Med 2021
604
100

Rethinking drug design in the artificial intelligence era.
Petra Schneider, W Patrick Walters, Alleyn T Plowright, Norman Sieroka, Jennifer Listgarten, Robert A Goodnow, Jasmin Fisher, Johanna M Jansen, José S Duca, Thomas S Rush,[...]. Nat Rev Drug Discov 2020
104
100


Novel anti-HIV cyclotriazadisulfonamide derivatives as modeled by ligand- and receptor-based approaches.
Júlia R Pinheiro, Michelle Bitencourt, Elaine F F da Cunha, Teodorico C Ramalho, Matheus P Freitas. Bioorg Med Chem 2008
16
100

In silico prediction of novel phosphodiesterase type-5 inhibitors derived from Sildenafil, Vardenafil and Tadalafil.
João E Antunes, Matheus P Freitas, Elaine F F da Cunha, Teodorico C Ramalho, Roberto Rittner. Bioorg Med Chem 2008
11
100

Carbamate and N-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors.
Derun Li, Yongqi Deng, Abdelghani Achab, Indu Bharathan, Brett Andrew Hopkins, Wensheng Yu, Hongjun Zhang, Sulagna Sanyal, Qinglin Pu, Hua Zhou,[...]. ACS Med Chem Lett 2021
6
100

The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit.
Alexandre Dias, Denis Bouvier, Thibaut Crépin, Andrew A McCarthy, Darren J Hart, Florence Baudin, Stephen Cusack, Rob W H Ruigrok. Nature 2009
482
100

Delivery aspects of small peptides and substrates for peptide transporters.
Bente Steffansen, Carsten Uhd Nielsen, Sven Frokjaer. Eur J Pharm Biopharm 2005
21
100

Computational Bioactivity Fingerprint Similarities To Navigate the Discovery of Novel Scaffolds.
Guo-Li Xiong, Yue Zhao, Lu Liu, Zhong-Ye Ma, Ai-Ping Lu, Yan Cheng, Ting-Jun Hou, Dong-Sheng Cao. J Med Chem 2021
2
100

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
David E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, Jiewei Xu, Kirsten Obernier, Kris M White, Matthew J O'Meara, Veronica V Rezelj, Jeffrey Z Guo, Danielle L Swaney,[...]. Nature 2020
100

Halogen bonding for rational drug design and new drug discovery.
Yunxiang Lu, Yingtao Liu, Zhijian Xu, Haiying Li, Honglai Liu, Weiliang Zhu. Expert Opin Drug Discov 2012
138
100

Recent advances in structure-based rational drug design.
P J Gane, P M Dean. Curr Opin Struct Biol 2000
113
100

Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity.
Brian H Harcourt, Dalia Jukneliene, Amornrat Kanjanahaluethai, John Bechill, Kari M Severson, Catherine M Smith, Paul A Rota, Susan C Baker. J Virol 2004
263
100

Hotspots API: A Python Package for the Detection of Small Molecule Binding Hotspots and Application to Structure-Based Drug Design.
Peter R Curran, Chris J Radoux, Mihaela D Smilova, Richard A Sykes, Alicia P Higueruelo, Anthony R Bradley, Brian D Marsden, David R Spring, Tom L Blundell, Andrew R Leach,[...]. J Chem Inf Model 2020
5
100

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
Nina H Schultz, Ingvild H Sørvoll, Annika E Michelsen, Ludvig A Munthe, Fridtjof Lund-Johansen, Maria T Ahlen, Markus Wiedmann, Anne-Hege Aamodt, Thor H Skattør, Geir E Tjønnfjord,[...]. N Engl J Med 2021
441
100

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
Wanbo Tai, Lei He, Xiujuan Zhang, Jing Pu, Denis Voronin, Shibo Jiang, Yusen Zhou, Lanying Du. Cell Mol Immunol 2020
663
100

A review on drug repurposing applicable to COVID-19.
Serena Dotolo, Anna Marabotti, Angelo Facchiano, Roberto Tagliaferri. Brief Bioinform 2021
37
100

Molecular Insights into the MAPK Cascade during Viral Infection: Potential Crosstalk between HCQ and HCQ Analogues.
Tapan Kumar Mohanta, Nanaocha Sharma, Pietro Arina, Paola Defilippi. Biomed Res Int 2020
5
100

OpenChem: A Deep Learning Toolkit for Computational Chemistry and Drug Design.
Maria Korshunova, Boris Ginsburg, Alexander Tropsha, Olexandr Isayev. J Chem Inf Model 2021
8
100

Advances in de Novo Drug Design: From Conventional to Machine Learning Methods.
Varnavas D Mouchlis, Antreas Afantitis, Angela Serra, Michele Fratello, Anastasios G Papadiamantis, Vassilis Aidinis, Iseult Lynch, Dario Greco, Georgia Melagraki. Int J Mol Sci 2021
11
100


Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches.
Javier Vázquez, Manel López, Enric Gibert, Enric Herrero, F Javier Luque. Molecules 2020
11
100

Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes.
Karolina Michalska, Youngchang Kim, Robert Jedrzejczak, Natalia I Maltseva, Lucy Stols, Michael Endres, Andrzej Joachimiak. IUCrJ 2020
48
100


Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease.
Alice Douangamath, Daren Fearon, Paul Gehrtz, Tobias Krojer, Petra Lukacik, C David Owen, Efrat Resnick, Claire Strain-Damerell, Anthony Aimon, Péter Ábrányi-Balogh,[...]. Nat Commun 2020
114
100

Computer-aided drug design against spike glycoprotein of SARS-CoV-2 to aid COVID-19 treatment.
Muhammad Shehroz, Tahreem Zaheer, Tanveer Hussain. Heliyon 2020
7
100

Optimal description of a protein structure in terms of multiple groups undergoing TLS motion.
Jay Painter, Ethan A Merritt. Acta Crystallogr D Biol Crystallogr 2006
100

Strategies in the rational drug design.
T Mavromoustakos, S Durdagi, C Koukoulitsa, M Simcic, M G Papadopoulos, M Hodoscek, S Golic Grdadolnik. Curr Med Chem 2011
48
100

DeepScaffold: A Comprehensive Tool for Scaffold-Based De Novo Drug Discovery Using Deep Learning.
Yibo Li, Jianxing Hu, Yanxing Wang, Jielong Zhou, Liangren Zhang, Zhenming Liu. J Chem Inf Model 2020
21
100

X-ray Scattering Studies of Protein Structural Dynamics.
Steve P Meisburger, William C Thomas, Maxwell B Watkins, Nozomi Ando. Chem Rev 2017
32
100

Target2DeNovoDrug: a novel programmatic tool for in silico-deep learning based de novo drug design for any target of interest.
Rafal Madaj, Ben Geoffrey, Akhil Sanker, Pavan Preetham Valluri. J Biomol Struct Dyn 2021
1
100

Structure-based virtual screening for drug discovery: a problem-centric review.
Tiejun Cheng, Qingliang Li, Zhigang Zhou, Yanli Wang, Stephen H Bryant. AAPS J 2012
266
100

Halogen atoms in the modern medicinal chemistry: hints for the drug design.
Marcelo Zaldini Hernandes, Suellen Melo T Cavalcanti, Diogo Rodrigo M Moreira, Walter Filgueira de Azevedo Junior, Ana Cristina Lima Leite. Curr Drug Targets 2010
292
100

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.
Marie Scully, Deepak Singh, Robert Lown, Anthony Poles, Tom Solomon, Marcel Levi, David Goldblatt, Pavel Kotoucek, William Thomas, William Lester. N Engl J Med 2021
298
100

Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents.
Hymavathi Veeravarapu, Vasavi Malkhed, Kiran Kumar Mustyala, Rajender Vadija, Ramesh Malikanti, Uma Vuruputuri, Murali Krishna Kumar Muthyala. Mol Divers 2021
2
100

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.
Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, Bing Zhang, Xiaofeng Li, Leike Zhang, Chao Peng,[...]. Nature 2020
100

Fragment Linking Strategies for Structure-Based Drug Design.
Alexandre Bancet, Claire Raingeval, Thierry Lomberget, Marc Le Borgne, Jean-François Guichou, Isabelle Krimm. J Med Chem 2020
15
100

Angiotensin converting enzyme inhibitors: 1-glutarylindoline-2-carboxylic acids derivatives.
N Gruenfeld, J L Stanton, A M Yuan, F H Ebetino, L J Browne, C Gude, C F Huebner. J Med Chem 1983
39
100

Positive selection as a key player for SARS-CoV-2 pathogenicity: Insights into ORF1ab, S and E genes.
Mohamed Emam, Mariam Oweda, Agostinho Antunes, Mohamed El-Hadidi. Virus Res 2021
3
100

DeepSite: protein-binding site predictor using 3D-convolutional neural networks.
J Jiménez, S Doerr, G Martínez-Rosell, A S Rose, G De Fabritiis. Bioinformatics 2017
115
100


Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
Balamurugan Shanmugaraj, Konlavat Siriwattananon, Kittikhun Wangkanont, Waranyoo Phoolcharoen. Asian Pac J Allergy Immunol 2020
211
100



Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin.
J Rahuel, V Rasetti, J Maibaum, H Rüeger, R Göschke, N C Cohen, S Stutz, F Cumin, W Fuhrer, J M Wood,[...]. Chem Biol 2000
209
100

Multi-target dopamine D3 receptor modulators: Actionable knowledge for drug design from molecular dynamics and machine learning.
Mariarosaria Ferraro, Sergio Decherchi, Alessio De Simone, Maurizio Recanatini, Andrea Cavalli, Giovanni Bottegoni. Eur J Med Chem 2020
8
100

Antiviral drug design based on the opening mechanism of spike glycoprotein in SARS-CoV-2.
Ruichao Mao, Lihua Bie, Maofeng Xu, Xiaocong Wang, Jun Gao. Phys Chem Chem Phys 2021
1
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.